Literature DB >> 3101617

Co-trimoxazole red cell aplasia in leukaemia.

C E Unter, G D Abbott.   

Abstract

A 4 year old boy with acute lymphoblastic leukaemia developed a pure red cell aplasia 13 months after entering remission and while on maintenance chemotherapy. Co-trimoxazole was also being administered for prophylaxis against Pneumocystis carinii infection. When co-trimoxazole was stopped the red cell aplasia resolved.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3101617      PMCID： PMC1778150          DOI： 10.1136/adc.62.1.85-a

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  6 in total

1.  Transient erythroid hypoplasia in a patient on long-term co-trimoxazole therapy.

Authors:  M E Stephens
Journal:  Postgrad Med J       Date:  1974-04       Impact factor: 2.401

2.  Co-trimoxazole prophylaxis in leukaemia.

Authors:  H C Drysdale; L F Jones
Journal:  Lancet       Date:  1982-02-20       Impact factor: 79.321

3.  Hematologic abnormalities after oral trimethoprim-sulfamethoxazole therapy in children.

Authors:  B I Asmar; S Maqbool; A S Dajani
Journal:  Am J Dis Child       Date:  1981-12

4.  Successful chemoprophylaxis for Pneumocystis carinii pneumonitis.

Authors:  W T Hughes; S Kuhn; S Chaudhary; S Feldman; M Verzosa; R J Aur; C Pratt; S L George
Journal:  N Engl J Med       Date:  1977-12-29       Impact factor: 91.245

5.  Myelosuppression associated with co-trimoxazole as a prophylactic antibiotic in the maintenance phase of childhood acute lymphocytic leukemia.

Authors:  W G Woods; A E Daigle; R J Hutchinson; L L Robison
Journal:  J Pediatr       Date:  1984-10       Impact factor: 4.406

6.  Selective erythroid aplasia during therapy for acute lymphoblastic leukemia.

Authors:  S E Sallan; G R Buchanan
Journal:  Pediatrics       Date:  1977-06       Impact factor: 7.124
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.